MeiraGTx (NASDAQ: MGTX) revenue
MeiraGTx reported revenue of $81.4m for fiscal 2025, 144.6% more than in fiscal 2024 ($33.3m). Since fiscal 2019 its revenue has grown by 512.3%, an average growth of 35.3% a year.
MeiraGTx has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 7 fiscal years on record. The biggest drop was in fiscal 2022, −57.8%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $81.4m | +144.6% | −$106.0m | −130.2% |
| 2024 | $33.3m | +137.4% | −$164.2m | −493.4% |
| 2023 | $14.0m | −12.0% | −$137.1m | −977.8% |
| 2022 | $15.9m | −57.8% | −$116.4m | −730.9% |
| 2021 | $37.7m | +142.2% | −$72.8m | −193.0% |
| 2020 | $15.6m | +17.1% | −$62.6m | −401.9% |
| 2019 | $13.3m | — | −$58.3m | −438.4% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
MeiraGTx revenue compared with its sector
By revenue for its latest fiscal year, MeiraGTx ranks 300th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; MeiraGTx, 144.6%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 298th | Iradimed | $83.8m | 14.4% |
| 299th | Arcturus Therapeutics | $82.0m | −46.1% |
| 300th | MeiraGTx | $81.4m | 144.6% |
| 301st | ADC Therapeutics | $81.4m | 14.9% |
| 302nd | ETON Pharmaceuticals | $80.0m | 104.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of MeiraGTx
- How much revenue did MeiraGTx make in fiscal 2025?
- MeiraGTx reported revenue of $81.4m for fiscal 2025, compared with $33.3m in fiscal 2024.
- How much has the revenue of MeiraGTx grown?
- Between fiscal 2019 and fiscal 2025 it went from $13.3m to $81.4m: 512.3% more, an average growth of 35.3% a year.
- What was the best year for revenue at MeiraGTx?
- Of its last 7 fiscal years, fiscal 2025, with $81.4m.
- Where does MeiraGTx rank in its sector by revenue?
- It ranks 300th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for MeiraGTx come from?
- From the annual report (Form 10-K) that MeiraGTx files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that MeiraGTx files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on MeiraGTx: the MeiraGTx page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.